Transition Therapeutics Inc.

101 College Street Suite 220
Toronto, Ontario M5G 1L7
Canada View Map >>

P: (416) 260-7770
F: (416) 260-2886
Transition is a biopharmaceutical development company, advancing novel therapeutics for CNS, metabolic diseases and androgen deficiency indications. The Company's wholly-owned subsidiary, Transition Therapeutics Ireland Limited, has two development programs: CNS drug candidate ELND005 for the treatment of Alzheimer's disease and Down syndrome; and ... more

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Contact People at this company

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Contact People at this company

Products & Services

biopharmaceutical, therapeutic, biotechnology


Biotechnology, Drug Manufacturing & Research, Business Services

Similar Companies

Novo Nordisk Inc, Biomira Inc., Lorus Therapeutics Inc., Vasogen Inc.

Stock Market


SIC Codes

2834, 2836, 8731


325412, 325414, 541711

Recently updated profiles at this company (21 contacts available)

Francis Briones
Director of Information Technology
Carl Damiani
Vice President of Business Development
Melissa Spencer
Senior Manager, Pharmaceutical Development and Manufacturing
City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory